NO970140L - Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene - Google Patents

Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene

Info

Publication number
NO970140L
NO970140L NO970140A NO970140A NO970140L NO 970140 L NO970140 L NO 970140L NO 970140 A NO970140 A NO 970140A NO 970140 A NO970140 A NO 970140A NO 970140 L NO970140 L NO 970140L
Authority
NO
Norway
Prior art keywords
complexes
agents
technetium
sulfonamide
preparation
Prior art date
Application number
NO970140A
Other languages
English (en)
Norwegian (no)
Other versions
NO970140D0 (no
Inventor
Johannes Platzek
Bernd Raduechel
Wolfgang Kramp
Ludger Dinkelborg
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO970140D0 publication Critical patent/NO970140D0/no
Publication of NO970140L publication Critical patent/NO970140L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16—Isothiocyanates
    • C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO970140A 1994-07-14 1997-01-13 Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene NO970140L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4425781A DE4425781A1 (de) 1994-07-14 1994-07-14 Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel
PCT/EP1995/002404 WO1996002500A1 (de) 1994-07-14 1995-06-22 Technetium-sulfonamid-komplexe, deren verwendung, diese enthaltende pharmazeutische mittel, sowie verfahren zur herstellung der komplexe und mittel

Publications (2)

Publication Number Publication Date
NO970140D0 NO970140D0 (no) 1997-01-13
NO970140L true NO970140L (no) 1997-03-13

Family

ID=6523740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970140A NO970140L (no) 1994-07-14 1997-01-13 Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene

Country Status (11)

Country Link
EP (1) EP0770063A1 (de)
JP (1) JPH10502648A (de)
KR (1) KR970704682A (de)
CN (1) CN1152914A (de)
AU (1) AU698824B2 (de)
CA (1) CA2194561A1 (de)
DE (1) DE4425781A1 (de)
HU (1) HUT76806A (de)
NO (1) NO970140L (de)
WO (1) WO1996002500A1 (de)
ZA (1) ZA955896B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DE60135752D1 (en) * 2000-07-06 2008-10-23 Array Biopharma Inc Tyrosinderivate als phosphatase inhibitoren
KR100445971B1 (ko) * 2002-04-15 2004-08-25 한국원자력연구소 수소화붕소 교환수지를 이용한 테크네튬 또는 레늄의표지방법
ES2500922T3 (es) * 2002-05-06 2014-10-01 Endocyte, Inc. Agentes de formación de imágenes dirigidos al receptor de folato

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
ES2017088B3 (es) * 1986-05-28 1991-01-01 Mallinckrodt Inc (A Missouri Corporation) Quelatos de tecnecio a utilizar para determinar la funcion renal.

Also Published As

Publication number Publication date
WO1996002500A1 (de) 1996-02-01
DE4425781A1 (de) 1996-01-18
EP0770063A1 (de) 1997-05-02
JPH10502648A (ja) 1998-03-10
CN1152914A (zh) 1997-06-25
KR970704682A (ko) 1997-09-06
AU2886595A (en) 1996-02-16
NO970140D0 (no) 1997-01-13
HUT76806A (en) 1997-11-28
CA2194561A1 (en) 1996-02-01
ZA955896B (en) 1996-02-19
AU698824B2 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
NO954440D0 (no) 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler
BR0109650A (pt) 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca
NO954342L (no) Erytropoietinanalogblandinger, samt fremgangsmåter ved fremstilling derav
MY126973A (en) Derivatives of 4-aminopiperidine and their use as a medicament
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
NO954441D0 (no) Tricyklopolyazamakrocyklofosfonsyrer, komplekser og derivater derav for anvendelse som kontrastmidler
NO180583C (no) Arylsulfonamido-substituerte hydroksamsyrer, farmasöytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
AP9701041A0 (en) Pyridylpyrrole compounds.
IL91292A0 (en) 13,17-propionic acid and propionic acid derivative substituted porphyrin complex compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
DK0386452T3 (da) Diphenylheteroalkylderivater, fremgangsmåde til fremstilling heraf og lægemidler og kosmetika indeholdende disse
DE69306212D1 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta-5alpha-Androstane, Androstene und Androstadiene, ein Verfahren zu ihrer Herstellung und pharmazeutische Präperate davon
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
CA2019404A1 (en) 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
IE883844L (en) Macrocyclic chelating agents and chelates thereof
NO970140L (no) Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene
ZA961395B (en) Metal complexes suitable for use in diagnosis and therapy
UA35623C2 (uk) Похідні аміду фенілциклогексилкарбонової кислоти, суміш їх ізомерів чи окремі ізомери і їх солі, фармацевтична композиція з антиартеріосклеротичною і антирестенозною активністю
TNSN99146A1 (fr) Derives de 1-heteroaryl-pyrrolidine, -piperidine et - homopiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
NO962243D0 (no) Halogenarylsubstituerte metallkomplekser, farmasöytiske midler inneholdende slike og deres anvendelse i diagnostikken, samt fremgangsmåte for fremstilling av slike komplekser og midler
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
SE0102058D0 (sv) New Salts II
ZA949347B (en) 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production.
EP0487996A3 (en) Cephalosporins substituted in position 3, process for their preparation and their use as medicine
MX9600165A (es) 3-alcoxicarbonil-tiadiazinonas, proceso para su preparacion y composiciones farmaceuticas que las contienen.